| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.06 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.08 | 0.06 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |